Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how OrthoPediatrics Corp. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $236.35M | $204.73M | $148.73M | $122.29M | $98.05M | $71.08M | $72.55M | $57.56M | $45.62M | $37.30M |
| Revenue Growth? | +15.4% | +37.6% | +21.6% | +24.7% | +37.9% | -2.0% | +26.0% | +26.2% | +22.3% | 0.0% |
| Cost of Revenue? | $63.69M | $56.13M | $37.48M | $31.63M | $24.65M | $16.05M | $17.93M | $14.88M | $11.17M | $10.93M |
| Gross Profit? | $172.66M | $148.60M | $111.25M | $90.66M | $73.40M | $55.03M | $54.62M | $42.68M | $34.45M | $26.37M |
| Gross Margin? | +73.1% | +72.6% | +74.8% | +74.1% | +74.9% | +77.4% | +75.3% | +74.2% | +75.5% | +70.7% |
| Operating Expenses? | $201.66M | $178.12M | $138.00M | $116.06M | $91.43M | $81.79M | $63.70M | $52.23M | $40.92M | $32.49M |
| Operating Income? | -$29.00M | -$29.52M | -$26.75M | -$25.40M | -$18.02M | -$26.75M | -$9.08M | -$9.55M | -$6.47M | -$6.13M |
| EBITDA? | -$7.88M | -$10.44M | -$8.38M | -$8.69M | -$7.19M | -$22.25M | -$4.51M | -$6.88M | -$4.04M | -$3.19M |
| Income Before Tax | -$39.19M | -$41.93M | -$21.31M | -$3.69M | -$17.39M | -$33.67M | -$12.69M | -$12.03M | -$8.93M | -$6.57M |
| Income Tax Expense | $460,000 | -$4.11M | -$338,000 | -$4.95M | -$1.13M | -$723,000 | $0 | $0 | $0 | $0 |
| Net Income? | -$39.65M | -$37.82M | -$20.97M | $1.26M | -$16.26M | -$32.94M | -$13.73M | -$12.03M | -$8.93M | -$6.57M |
| EPS? | $-1.69 | $-1.64 | $-0.92 | $0.06 | $-0.84 | $-1.82 | $-1.18 | $-0.96 | $-1.85 | $-0.87 |
| Diluted EPS? | $-1.69 | $-1.64 | $-0.92 | $0.06 | $-0.84 | $-1.82 | $-1.18 | $-0.96 | $-1.85 | $-0.87 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality